Abstract

Background

Oncrasin-1 is a small molecule which was identified from a screen of KRAS mutant cancer cells and has shown specificity for KRAS mutant cell killing. We aimed to develop a radiolabelled form of Oncrasin-1 to enable in-vivo imaging of mutant KRAS expression in malignant tumours. This work outlines the synthesis of 3 fluorinated derivatives and development of iodonium salt and boronic ester precursors for radiolabelling with the 18F isotope.

Results

In our hands, synthesis of iodonium salts were not easily accessible due to the 3-carbaldehyde indole structure being preferentially oxidized by conditions required for iodonium salt formation, rather than benzyl iodide. Synthesis and radiolabelling of boronic acid pinacol ester precursors were successful, with the products being obtained in yields of 10.76% ± 0.96% (n = 5), 14.7% ±8.58% (n = 3) and 14.92% ±3.9% (n = 3) for 18F KAM001, 18F KAM002 and 18F KAM003 respectively, with radiochemical purity of greater than 99%.

Conclusions

The successful synthesis of these tracers has been undertaken utilizing boronic ester radio-fluorination methods and will allow for investigation of Oncrasin based molecules as potential diagnostics for cancers expressing mutant KRAS protein.

Details

Title
Automated synthesis of 18F radiolabelled indole containing Oncrasin-like molecules; a comparison of iodonium salts and boronic ester chemistry
Author
McDonald, Alexander F 1   VIAFID ORCID Logo  ; Goh, Yit Wooi 2 ; White, Jonathan M 3   VIAFID ORCID Logo  ; Scott, Andrew M 4   VIAFID ORCID Logo  ; Ackermann Uwe 4 

 La Trobe University, The Olivia Newton-John Cancer Research Insititute, and School of Cancer Medicine, Heidelberg, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938); Austin Health, Department of Molecular Imaging and Therapy, Heidelberg, Australia (GRID:grid.410678.c); The University of Melbourne, School of Chemistry, Bio21 Institute, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Melbourne, Australia (GRID:grid.1008.9) 
 The University of Melbourne, School of Chemistry, Bio21 Institute, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 La Trobe University, The Olivia Newton-John Cancer Research Insititute, and School of Cancer Medicine, Heidelberg, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938); Austin Health, Department of Molecular Imaging and Therapy, Heidelberg, Australia (GRID:grid.410678.c); The University of Melbourne, Faculty of Medicine, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
Publication year
2020
Publication date
Dec 2020
Publisher
Springer Nature B.V.
e-ISSN
2365-421X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471567966
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.